{"id":"https://openalex.org/W4362548342","doi":"https://doi.org/10.1158/2767-9764.22546789","title":"Supplemental Figure 3 from Digital spatial profiling links beta-2-microglobulin expression with immune checkpoint blockade outcomes in head and neck squamous cell carcinoma","display_name":"Supplemental Figure 3 from Digital spatial profiling links beta-2-microglobulin expression with immune checkpoint blockade outcomes in head and neck squamous cell carcinoma","publication_year":2023,"publication_date":"2023-04-04","ids":{"openalex":"https://openalex.org/W4362548342","doi":"https://doi.org/10.1158/2767-9764.22546789"},"language":"en","primary_location":{"id":"doi:10.1158/2767-9764.22546789","doi":"https://doi.org/10.1158/2767-9764.22546789","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2767-9764.22546789","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplemental_Figure_3_from_Digital_spatial_profiling_links_beta-2-microglobulin_expression_with_immune_checkpoint_blockade_outcomes_in_head_and_neck_squamous_cell_carcinoma/22546789/1/files/40010281.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://aacr.figshare.com/articles/journal_contribution/Supplemental_Figure_3_from_Digital_spatial_profiling_links_beta-2-microglobulin_expression_with_immune_checkpoint_blockade_outcomes_in_head_and_neck_squamous_cell_carcinoma/22546789/1/files/40010281.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5009081688","display_name":"Niki Gavrielatou","orcid":"https://orcid.org/0000-0003-1380-6831","observed_orcids":["https://orcid.org/0000-0003-1380-6831"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Niki Gavrielatou","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-1380-6831","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003079520","display_name":"Ioannis A. Vathiotis","orcid":"https://orcid.org/0000-0003-3467-7629","observed_orcids":["https://orcid.org/0000-0003-3467-7629"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ioannis A. Vathiotis","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-3467-7629","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011946828","display_name":"Thazin Nwe Aung","orcid":"https://orcid.org/0000-0003-4150-0426","observed_orcids":["https://orcid.org/0000-0003-4150-0426"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thazin Nwe Aung","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-4150-0426","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087794278","display_name":"Saba Shafi","orcid":"https://orcid.org/0000-0002-8468-2402","observed_orcids":["https://orcid.org/0000-0002-8468-2402","https://orcid.org/0009-0008-1662-4842"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Saba Shafi","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-8468-2402","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009801511","display_name":"Sneha Burela","orcid":"https://orcid.org/0000-0003-0287-0336","observed_orcids":["https://orcid.org/0000-0003-0287-0336"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sneha Burela","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0287-0336","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058852546","display_name":"Aileen I. Fernandez","orcid":"https://orcid.org/0000-0001-7442-6635","observed_orcids":["https://orcid.org/0000-0001-7442-6635"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Aileen I. Fernandez","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7442-6635","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085694950","display_name":"Myrto K. Moutafi","orcid":"https://orcid.org/0000-0002-9314-3187","observed_orcids":["https://orcid.org/0000-0002-9314-3187"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Myrto Moutafi","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9314-3187","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023000705","display_name":"Barbara Ann Burtness","orcid":"https://orcid.org/0000-0003-4660-1859","observed_orcids":["https://orcid.org/0000-0003-4660-1859"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Barbara A. Burtness","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-4660-1859","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003736175","display_name":"Panagiota Economopoulou","orcid":"https://orcid.org/0000-0001-8871-3264","observed_orcids":["https://orcid.org/0000-0001-8871-3264"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Panagiota Economopoulou","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8871-3264","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040756384","display_name":"\u039caria Anastasiou","orcid":"https://orcid.org/0000-0003-0047-8090","observed_orcids":["https://orcid.org/0000-0003-0047-8090"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maria Anastasiou","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0047-8090","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017439064","display_name":"Periklis G. Foukas","orcid":"https://orcid.org/0000-0002-6053-7841","observed_orcids":["https://orcid.org/0000-0002-6053-7841"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Periklis Foukas","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-6053-7841","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063134810","display_name":"Amanda K. Psyrri","orcid":"https://orcid.org/0000-0002-4321-766X","observed_orcids":["https://orcid.org/0000-0002-4321-766X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Amanda Psyrri","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-4321-766X","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5027326018","display_name":"David L. Rimm","orcid":"https://orcid.org/0000-0001-5820-4397","observed_orcids":["https://orcid.org/0000-0001-5820-4397"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David L. Rimm","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-5820-4397","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10307","display_name":"Head and Neck Cancer Studies","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/2733","display_name":"Otorhinolaryngology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/beta2-microglobulin","display_name":"beta2-microglobulin","score":0.996999979019165},{"id":"https://openalex.org/keywords/head-and-neck-squamous-cell-carcinoma","display_name":"head and neck squamous cell carcinoma","score":0.9110000133514404},{"id":"https://openalex.org/keywords/immune-checkpoint-blockade","display_name":"immune checkpoint blockade","score":0.9679999947547913},{"id":"https://openalex.org/keywords/digital-spatial-profiling","display_name":"digital spatial profiling","score":0.8130000233650208},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.8799999952316284},{"id":"https://openalex.org/keywords/disease-control","display_name":"disease control","score":0.7799999713897705},{"id":"https://openalex.org/keywords/mrna-protein-correlation","display_name":"mRNA-protein correlation","score":0.6389999985694885}],"concepts":[{"id":"https://openalex.org/C2776833033","wikidata":"https://www.wikidata.org/wiki/Q1783924","display_name":"Head and neck squamous-cell carcinoma","level":4,"score":0.6949857473373413},{"id":"https://openalex.org/C21957315","wikidata":"https://www.wikidata.org/wiki/Q287896","display_name":"Beta-2 microglobulin","level":2,"score":0.6580134630203247},{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.6339461803436279},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.5716348886489868},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5629265308380127},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.5527967214584351},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5251333713531494},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4729340374469757},{"id":"https://openalex.org/C105580179","wikidata":"https://www.wikidata.org/wiki/Q188928","display_name":"Messenger RNA","level":3,"score":0.4694765508174896},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.43496352434158325},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.4345114529132843},{"id":"https://openalex.org/C6856738","wikidata":"https://www.wikidata.org/wiki/Q331672","display_name":"Protein expression","level":3,"score":0.4265105426311493},{"id":"https://openalex.org/C2776530083","wikidata":"https://www.wikidata.org/wiki/Q1783924","display_name":"Head and neck cancer","level":3,"score":0.32114142179489136},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2888377904891968},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2793782353401184},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.1507638692855835},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.10470736026763916},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.09115469455718994},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1158/2767-9764.22546789","doi":"https://doi.org/10.1158/2767-9764.22546789","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2767-9764.22546789","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplemental_Figure_3_from_Digital_spatial_profiling_links_beta-2-microglobulin_expression_with_immune_checkpoint_blockade_outcomes_in_head_and_neck_squamous_cell_carcinoma/22546789/1/files/40010281.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/2767-9764.22546789.v1","doi":"https://doi.org/10.1158/2767-9764.22546789.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/2767-9764.22546789.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22546789","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplemental_Figure_3_from_Digital_spatial_profiling_links_beta-2-microglobulin_expression_with_immune_checkpoint_blockade_outcomes_in_head_and_neck_squamous_cell_carcinoma/22546789","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/2767-9764.22546789","doi":"https://doi.org/10.1158/2767-9764.22546789","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2767-9764.22546789","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplemental_Figure_3_from_Digital_spatial_profiling_links_beta-2-microglobulin_expression_with_immune_checkpoint_blockade_outcomes_in_head_and_neck_squamous_cell_carcinoma/22546789/1/files/40010281.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4362548342.pdf","grobid_xml":"https://content.openalex.org/works/W4362548342.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4323542890","https://openalex.org/W4362548116","https://openalex.org/W7147388391","https://openalex.org/W4294975096","https://openalex.org/W4406240518","https://openalex.org/W4390423145","https://openalex.org/W7165108831","https://openalex.org/W4388967853","https://openalex.org/W7146975886","https://openalex.org/W3170676376"],"abstract_inverted_index":{"correlation":[0],"of":[1,12],"b2m":[2],"protein":[3],"with":[4,16],"B2M":[5,13],"mRNA":[6,14],"expression":[7],"in":[8],"Athens":[9],"cohort.":[10],"Association":[11],"levels":[15],"response":[17],"and":[18],"disease":[19],"control":[20]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-06T00:00:00"}